pros and cons of autologous and allogeneic car-ts
Published 2 years ago • 901 plays • Length 2:46Download video MP4
Download video MP3
Similar videos
-
1:59
autologous and allogeneic car-ts & the role of academia within this field
-
1:22
the role of autologous and allogeneic transplant in the era of car-t for patients with lymphoma
-
3:24
allogeneic car-t technology
-
2:06
car-t therapy vs autologous transplantation in r/r dlbcl
-
1:39
the role of myeloid cells in car-t cell therapy
-
2:20
patient experience of car-t vs. hsct
-
1:08
advantages and current status of off-the-shelf car-ts
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
14:18
day 2 round up: targeting aml, progress in myeloma and allogeneic car-ts
-
2:47
advances in allogeneic car-t therapy in lymphoma
-
1:33
patient selection for car-t in all
-
1:39
exploring the applications of car-ts beyond hematology and oncology
-
3:57
comparing bmt and car-t therapy: learnings for patient care and management
-
4:23
carcik-cd19: allogeneic and non-viral car t-cells
-
1:26
an insight into ctx130: a novel allogeneic car-t cell therapy
-
3:47
update on the guidelines for the diagnosis, grading & management of icaht following car-t therapy
-
1:26
the safety and efficacy of allosct following car-t cell therapy for large b-cell lymphoma
-
1:13
car-t nursing education